Top Markets
Coin of the day
Atrion Corporation Atrion Corporation

Atrion Corporation

ATRI
Classifica tra le azioni #38752
Atrion Corporation, along with its affiliated entities, specializes in the... Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.
Prezzo delle azioni
$0.45992
Ultima sincronizzazione: 2024-08-30
Capitalizzazione di mercato
$821.42K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Atrion Corporation (ATRI)

Categoria

Rapporto P/E per Atrion Corporation (ATRI)
Rapporto P/E al August 2026 TTM: 41.74
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Atrion Corporation, il rapporto P/E attuale (TTM) è 41.74. Alla fine del 2022, il rapporto P/E era 28.56.
Storico del rapporto P/E per Atrion Corporation da 2000 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
2026 (TTM) 41.74 21.46%
2023 34.36 20.33%
2022 28.56 -26.18%
2021 38.68 5.36%
2020 36.72 -3.18%
2019 37.92 -5.40%
2018 40.09 26.02%
2017 31.81 -5.16%
2016 33.54 37.87%
2015 24.33 1.62%
2014 23.94 6.87%
2013 22.40 33.96%
2012 16.72 -10.23%
2011 18.63 7.77%
2010 17.28 -5.53%
2009 18.30 50.54%
2008 12.15 -27.83%
2007 16.84 25.99%
2006 13.37 -3.87%
2005 13.90 13.98%
2004 12.20 -17.96%
2002 14.87 87.49%
2001 7.93 -26.66%
2000 10.81 0.00%
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
39.92 -4.34%
US
30.38 -27.21%
FR
- -
JP
41.93 0.47%
US
- -
CH
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.